Companies: 10,795·Total market cap: $144.5T

Twist Bioscience Corporation

Twist Bioscience Corporation

TWSTNASDAQHealthcare● Active

$70.04

+$0.82(+1.18%)

Market Cap$4.4B

P/E Ratio—

52W High$80.5

52W Low$23.3

Avg Volume1.3M

Open$70.71

Beta2.21

股票排行：Medical - Diagnostics & Research·Healthcare·查看全部市值排行 →

Twist Bioscience Corporation（TWST）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · TWST · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-1.32Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$409.5MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding59.8MShares outstanding history

Next EarningsAug 3, 2026Est.Earnings history

探索 Twist Bioscience Corporation 数据

分析师预测$64 · Buy

股息不分红

营收$376.6M+20.32%

盈利EPS $-1.30+63.89%

财务快照

FY 2025Revenue$376.6M▲ +20.32% YoY

202320242025

FY 2025Net Income-$77.7M▲ +62.79% YoY

202320242025

FY 2025EPS$-1.30▲ +63.89% YoY

202320242025

TTM:Revenue: $409.5MNet Income: -$81.3MEPS: $-1.32View income statement →

分析师评级与目标价

Buy13 位分析师

Strong Buy

0

Buy

11

Hold

1

Sell

1

Strong Sell

0

12-Month Price Target

$52.00Low

$70.04Current

$64.40Avg Target下行风险 8.05%

$80.00High

合计: 13 · 买入占比: 84.6%

根据过去 3 个月内 13 位华尔街分析师，TWST 共识评级为 Buy，12 个月平均目标价 $64.40 （较现价 $70.04 下行风险 8.05%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Twist Bioscience Corporation

$70.04+1.18%$4.4B #2

$0.32+9.93%$64.2M #3

Clover Health Investments, Corp.

$3.92+2.35%$2.0B #4

Edgewise Therapeutics, Inc.

$34.84-2.11%$3.7B #5

Structure Therapeutics Inc.

$37.77+0.51%$2.2B #6

Guardian Pharmacy Services, Inc.

$40.51+0.07%$2.6B

股票表现

1D+1.18%

1W+0.33%

1M+23.20%

3M+49.21%

YTD+120.81%

1Y+109.95%

5Y-33.30%

关于 Twist Bioscience Corporation

CEOEmily Marine Leproust

IPO DateOct 31, 2018

Employees923

CountryUS

Websitetwistbioscience.com

Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthes…

Medical - Diagnostics & Research HealthcareNASDAQUS

关于股票概览与关键数据

Twist Bioscience Corporation（TWST）是 Medical - Diagnostics & Research 行业的 Healthcare 类公司，于 Oct 31, 2018 在 NASDAQ 上市。截至最近交易日，TWST 股价为 $70.04，市值约为 $4.4B。过去12个月累计回报 +109.95%，年初至今回报 +120.81%。

根据 13 位华尔街分析师，Twist Bioscience Corporation 股票共识评级为Buy，12个月平均目标价为 $64.40。2025 财年 Twist Bioscience Corporation 营收 $376.6M，净利润 -$77.7M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Twist Bioscience Corporation（TWST）股价为 $70.04，在 NASDAQ 上市，52周区间为 $23.30 – $80.50。

TWST 最新股价TWST quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议